M3TRIQ is an AI-driven biotech company pioneering the future of drug discovery by designing protein-ligand interactions with large language model (LLM) agents. Our proprietary platform integrates cutting-edge machine learning, structural bioinformatics, and cheminformatics to accelerate the identification and optimization of target-specific ligands. By transforming natural language into actionable molecular design workflows, M3TRIQ enables scientists to simulate, analyze, and refine drug candidates with unprecedented speed and precision. Our mission is to democratize molecular innovation, reduce R&D costs, and unlock new possibilities in therapeutic development—especially in underexplored or emerging markets.
